EE256 Budget Impact Analysis of the Introduction of a Novel Gene Expression Biomarker Test for Early-Stage Breast Cancer Patients in Cyprus
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.504
https://www.valueinhealthjournal.com/article/S1098-3015(22)02708-5/fulltext
Title :
EE256 Budget Impact Analysis of the Introduction of a Novel Gene Expression Biomarker Test for Early-Stage Breast Cancer Patients in Cyprus
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02708-5&doi=10.1016/j.jval.2022.09.504
First page :
Section Title :
Open access? :
No
Section Order :
10028